A cup of unsweetened, decaffeinated green tea in the evening could support blood sugar stability, complementing healthy habits for better glucose control, research indicates. A cup of unsweetened, decaffeinated green tea in the evening may be a sensible choice for…
With summer travel underway, Diabetes UK and footwear brand Gentle Grip warn that walking barefoot on hot sand or beaches can cause severe foot problems for diabetics, urging protective measures to prevent infections and amputations. People with diabetes are being…
Diabetic neuropathy can develop silently with subtle symptoms like tingling and numbness, but early detection through daily foot checks and blood sugar control is crucial to prevent severe nerve damage and related complications. Diabetic neuropathy can develop quietly, with early…
Novo Nordisk sues Eli Lilly over misleading advertising comparing dosages of GLP-1 weight-loss drugs, raising concerns about how clinical data is presented to consumers amidst ongoing regulatory scrutiny. Novo Nordisk’s lawsuit against Eli Lilly is turning a technical dispute over…
Biomae Fusion has completed patient enrolment in its phase II trial of icovamenib, a potential breakthrough in insulin-deficient type 2 diabetes, with results now expected in early 2027, signalling a significant step forward for the experimental drug. Biomae Fusion said…
New research presented at the European Association for the Study of Diabetes 2026 meeting reveals a nearly tenfold increase in type 2 diabetes among Colorado teenagers over two decades, underscoring the critical importance of early diagnosis and preventative measures. New…
South Korean biotech Hanmi Pharm has entered a multibillion-dollar licensing agreement with Genentech to co-develop a promising obesity drug candidate, marking a significant milestone in personalised obesity therapy. Hanmi Pharm has struck an exclusive licensing deal with Genentech for HM17321,…
Eli Lilly’s Foundayo, the first approved once-daily GLP-1 tablet in Europe, is now available in UK pharmacies, offering a new oral treatment option for weight management and diabetes control, potentially expanding access for patients unable to use injectable medicines. A…
Research indicates that the triglyceride-glucose (TyG) index, a simple blood test tool, could help identify adolescents at risk of developing hypertension, heralding a shift in early cardiovascular risk screening for teens. A routine blood calculation is gaining traction as a…
Endocrinologist Tsai Ming-chieh highlights that lactose-free milk, often considered a gentle alternative for those with lactose intolerance, can still impact blood glucose levels, emphasizing the importance of checking nutrition labels for those managing diabetes or weight. Lactose-free milk is often…
